HAE Haemonetics Corporation Common Stock
$102,60
السعر · أغسطس 18, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$47–$106
94% of range
تقييم المحللين
BUY
15 analysts
السعر المستهدف
$96
P/E (TTM)
50.0
ROE
11.8%
هامش صافي الربح
7.3%
حول Haemonetics Corporation Common Stock نظرة عامة على الشركة من ويكيبيديا
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
اقرأ المزيد
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
HAE لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$102.59
القيمة السوقية
$4.64B
P/E (TTM)
50.0
ربح السهم (آخر 12 شهرًا)
$2.05
الإيرادات (آخر 12 شهرًا)
$1.33B
عائد التوزيعات
—
ROE
11.8%
D/E الدين/حقوق الملكية
1.5
نطاق 52 أسبوعًا
$47 – $106
HAE مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$1.33B
2017-04-01
→
2026-03-28
ربح السهم
$2.05
2017-04-01
→
2026-03-28
التدفق النقدي الحر
$260M
2017-04-01
→
2026-03-28
الهوامش
7.3%
2017-04-01
→
2026-03-28
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
HAE
متوسط الأقران
P/E (TTM)
50.0
39.4
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
3.5
2.1
P/B (السعر / القيمة الدفترية)
5.8
3.3
EV / EBITDA
35.9
—
Price / FCF (السعر / التدفق النقدي الحر)
17.8
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
HAE
متوسط الأقران
Gross Margin (هامش الربح الإجمالي)
59.0%
58.7%
Operating Margin (هامش التشغيل)
11.8%
—
Net Profit Margin (هامش صافي الربح)
7.3%
-11.8%
ROA (العائد على الأصول)
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
HAE
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
1.5
37.4
Current Ratio (النسبة الحالية)
3.0
2.4
Quick Ratio (النسبة السريعة)
1.6
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
HAE
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
-2.0%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
4.5%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
8.9%
—
EPS YoY (ربحية السهم على أساس سنوي)
-38.1%
—
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
-42.0%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
HAE
متوسط الأقران
HAE توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
15 محللين
- شراء قوي 5 33,3%
- شراء 6 40,0%
- احتفاظ 4 26,7%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
10 محللين · 2026-08-13
الوسيط
$95.50
الآن
$102.59
منخفض
$86.00
مرتفع
$105.00
السعر المستهدف الوسيط
$95.50
-6,9%
السعر المستهدف المتوسط
$96.20
-6,2%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.06%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2027 | $1.14 | $1.09 | 0.05% |
| 30 يونيو، 2026 | $1.14 | $1.09 | 0.05% |
| 31 مارس، 2026 | $1.29 | $1.28 | 0.01% |
| 31 ديسمبر، 2025 | $1.31 | $1.26 | 0.05% |
| 30 سبتمبر، 2025 | $1.27 | $1.12 | 0.15% |
| 30 يونيو، 2025 | $1.10 | $1.03 | 0.07% |
| 31 مارس، 2025 | $1.24 | $1.23 | 0.01% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
الميزانية العمومية 25
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
التدفق النقدي 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
الربحية 8
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
السيولة والملاءة 4
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
الكفاءة 3
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
معدلات النمو 9
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
قائمة الدخل 16
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
الميزانية العمومية 25
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
التدفق النقدي 13
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
الربحية 8
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
السيولة والملاءة 4
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
الكفاءة 3
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| الإيرادات | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| هامش الربح الإجمالي % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| هامش الربح التشغيلي % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| صافي الدخل | $97M | $168M | $118M | $115M | $43M |
| EPS المخفف | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
الميزانية العمومية
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| النسبة الحالية | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| النسبة السريعة | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
التدفق النقدي
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $260M | $142M | $115M | $163M | $76M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 361 مقدمي إقرار · $2.6B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 61 (+8 مقابل الربع السابق) | 42 (-14 مقابل الربع السابق) | 108 (-4 مقابل الربع السابق) | 112 (-2 مقابل الربع السابق) | +6.3M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349945961 | 4366138 | 13,44% | الأسهم |
| NEUBERGER BERMAN GROUP LLC | $308172249 | 4108761 | 11,84% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190979550 | 2546394 | 7,34% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $154468350 | 2059578 | 5,93% | الأسهم |
| STATE STREET CORP | $136363950 | 1818186 | 5,24% | الأسهم |
| CITADEL ADVISORS LLC | $113259000 | 1510120 | 4,35% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $109143975 | 1455253 | 4,19% | الأسهم |
| River Road Asset Management, LLC | $96420150 | 1285602 | 3,70% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86651325 | 1155351 | 3,33% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $79315930 | 1057321 | 3,05% | الأسهم |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62319375 | 830925 | 2,39% | الأسهم |
| GOLDMAN SACHS GROUP INC | $52644150 | 701922 | 2,02% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44356725 | 591423 | 1,70% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $42780975 | 570413 | 1,64% | الأسهم |
| Holocene Advisors, LP | $41264625 | 550195 | 1,59% | الأسهم |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37034909 | 493796 | 1,42% | الأسهم |
| North Peak Capital Management, LLC | $25730775 | 343077 | 0,99% | الأسهم |
| LONDON CO OF VIRGINIA | $25543299 | 340574 | 0,98% | الأسهم |
| DEUTSCHE BANK AG\ | $25282575 | 337101 | 0,97% | الأسهم |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24905625 | 332075 | 0,96% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $24779850 | 330398 | 0,95% | الأسهم |
| Boston Trust Walden Corp | $24170475 | 322273 | 0,93% | الأسهم |
| Aristotle Capital Boston, LLC | $21721809 | 289624 | 0,83% | الأسهم |
| MIZUHO MARKETS AMERICAS LLC | $21166050 | 282214 | 0,81% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $20122875 | 268305 | 0,77% | الأسهم |
| Invenomic Capital Management LP | $16216275 | 216217 | 0,62% | الأسهم |
| FMR LLC | $15638325 | 208511 | 0,60% | الأسهم |
| HEARTLAND ADVISORS INC | $15000000 | 200000 | 0,58% | الأسهم |
| GLENMEDE TRUST CO NA | $14454000 | 192720 | 0,56% | الأسهم |
| MORGAN STANLEY | $13073475 | 174313 | 0,50% | الأسهم |
| Longaeva Partners L.P. | $12286650 | 163822 | 0,47% | الأسهم |
| RHUMBLINE ADVISERS | $10812225 | 144163 | 0,42% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $10613250 | 141510 | 0,41% | الأسهم |
| Balyasny Asset Management L.P. | $10123575 | 134981 | 0,39% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $9750000 | 130000 | 0,37% | الأسهم |
| Point72 Asset Management, L.P. | $8192700 | 109236 | 0,31% | الأسهم |
| Verition Fund Management LLC | $7913100 | 105508 | 0,30% | الأسهم |
| ARIEL INVESTMENTS, LLC | $7569975 | 100933 | 0,29% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $7500000 | 100000 | 0,29% | عقد خيار الشراء |
| KESTREL INVESTMENT MANAGEMENT CORP | $7305000 | 97400 | 0,28% | الأسهم |
| Divisadero Street Capital Management, LP | $7234425 | 96459 | 0,28% | الأسهم |
| Swiss National Bank | $6997500 | 93300 | 0,27% | الأسهم |
| GOLDMAN SACHS GROUP INC | $6750000 | 90000 | 0,26% | عقد خيار الشراء |
| GOLDMAN SACHS GROUP INC | $6750000 | 90000 | 0,26% | عقد خيار البيع |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6510000 | 86800 | 0,25% | عقد خيار الشراء |
| Squarepoint Ops LLC | $6459300 | 86124 | 0,25% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $6215025 | 82867 | 0,24% | الأسهم |
| Quantinno Capital Management LP | $5477550 | 73034 | 0,21% | الأسهم |
| ROYCE & ASSOCIATES LP | $5360625 | 71475 | 0,21% | الأسهم |
| AMERIPRISE FINANCIAL INC | $5358525 | 71447 | 0,21% | الأسهم |
| JUPITER ASSET MANAGEMENT LTD | $5229300 | 69724 | 0,20% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $5166634 | 91672 | 0,20% | الأسهم |
| SEGALL BRYANT & HAMILL, LLC | $5106900 | 68092 | 0,20% | الأسهم |
| AMERICAN CAPITAL MANAGEMENT INC | $5018625 | 66915 | 0,19% | الأسهم |
| ISTHMUS PARTNERS, LLC | $4946325 | 65951 | 0,19% | الأسهم |
| Corient Private Wealth LP | $4851975 | 64693 | 0,19% | الأسهم |
| FIRST TRUST ADVISORS LP | $4751850 | 63358 | 0,18% | الأسهم |
| DEAN INVESTMENT ASSOCIATES, LLC | $4649175 | 61989 | 0,18% | الأسهم |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4497450 | 59966 | 0,17% | الأسهم |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4484325 | 59791 | 0,17% | الأسهم |
| Bridgewater Associates, LP | $4479975 | 59733 | 0,17% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $4181475 | 55753 | 0,16% | الأسهم |
| Trexquant Investment LP | $3946425 | 52619 | 0,15% | الأسهم |
| Aequim Alternative Investments LP | $3840000 | 51200 | 0,15% | الأسهم |
| RICE HALL JAMES & ASSOCIATES, LLC | $3827850 | 51038 | 0,15% | الأسهم |
| JANE STREET GROUP, LLC | $3682500 | 49100 | 0,14% | عقد خيار الشراء |
| MetLife Investment Management, LLC | $3681075 | 49081 | 0,14% | الأسهم |
| BlackRock, Inc. | $3618975 | 48253 | 0,14% | الأسهم |
| Retirement Systems of Alabama | $3604875 | 48065 | 0,14% | الأسهم |
| Riverwater Partners LLC | $3573375 | 47645 | 0,14% | الأسهم |
| Skylands Capital, LLC | $3571875 | 47625 | 0,14% | الأسهم |
| FIFTH THIRD BANCORP | $3561472 | 47486 | 0,14% | الأسهم |
| ALGERT GLOBAL LLC | $3522750 | 46970 | 0,14% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $3441750 | 45890 | 0,13% | الأسهم |
| Qube Research & Technologies Ltd | $3425475 | 45673 | 0,13% | الأسهم |
| Dean Capital Management | $3372600 | 44968 | 0,13% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $3351375 | 44685 | 0,13% | الأسهم |
| EASTERLY INVESTMENT PARTNERS LLC | $3248025 | 43307 | 0,12% | الأسهم |
| Phocas Financial Corp. | $3227250 | 43030 | 0,12% | الأسهم |
| ZB,N.A. | $3200968 | 40996 | 0,12% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3190200 | 42536 | 0,12% | الأسهم |
| CONNORS INVESTOR SERVICES INC | $3150000 | 42000 | 0,12% | الأسهم |
| Expect Equity LLC | $3076950 | 41026 | 0,12% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2964874 | 52606 | 0,11% | الأسهم |
| BEACON INVESTMENT ADVISORS LLC | $2783648 | 37115 | 0,11% | الأسهم |
| Campbell & CO Investment Adviser LLC | $2763300 | 36844 | 0,11% | الأسهم |
| Assenagon Asset Management S.A. | $2633175 | 35109 | 0,10% | الأسهم |
| BARCLAYS PLC | $2448300 | 32644 | 0,09% | الأسهم |
| MARSHALL WACE, LLP | $2286975 | 30493 | 0,09% | الأسهم |
| Cubist Systematic Strategies, LLC | $2219702 | 45541 | 0,09% | الأسهم |
| XTX Topco Ltd | $2208150 | 29442 | 0,08% | الأسهم |
| Legal & General Group Plc | $2032875 | 27105 | 0,08% | الأسهم |
| CARY STREET PARTNERS FINANCIAL LLC | $1999800 | 26664 | 0,08% | الأسهم |
| Nierenberg Investment Management Company, LLC | $1971000 | 26280 | 0,08% | الأسهم |
| Aurora Investment Counsel | $1912575 | 25501 | 0,07% | الأسهم |
| WESBANCO BANK INC | $1912500 | 25500 | 0,07% | الأسهم |
| Cardinal Capital Management | $1861275 | 24817 | 0,07% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $1846275 | 24617 | 0,07% | الأسهم |
| Legato Capital Management LLC | $1758750 | 23450 | 0,07% | الأسهم |
| CITADEL ADVISORS LLC | $1740000 | 23200 | 0,07% | عقد خيار الشراء |
المطلعون على الشركة 72 من المطلعين · مسؤولون 48 · مديرون 25
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15 مايو، 2026 A | 444704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15 سبتمبر، 2015 M | 147040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15 مايو، 2026 A | 54444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23 أغسطس، 2021 M | 30291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13 يناير، 2016 A | 56743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 1 نوفمبر، 2006 P | 2101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26 يوليو، 2024 S | 18196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25 أكتوبر، 2016 A | 23318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 6 يوليو، 2015 M | 34102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11 نوفمبر، 2013 M | 10987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 3 مايو، 2012 M | 4442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 8 أغسطس، 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 1 مايو، 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28 نوفمبر، 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14 يونيو، 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 1 نوفمبر، 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 2 مايو، 2005 P | 2347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15 مايو، 2026 A | 32936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23 أكتوبر، 2015 S | 16891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 5 يونيو، 2026 F | 6242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 5 يونيو، 2026 F | 40987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15 مايو، 2026 A | 39882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15 مايو، 2026 A | 68829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12 يوليو، 2024 S | 21331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28 مايو، 2024 F | 30940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13 يونيو، 2022 S | 4447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 7 يونيو، 2021 S | 4216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11 نوفمبر، 2019 S | 1977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 7 يونيو، 2018 S | 15226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25 أكتوبر، 2016 A | 16867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25 أكتوبر، 2016 A | 48166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26 أكتوبر، 2015 S | 30507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26 أكتوبر، 2015 S | 20464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23 أكتوبر، 2015 S | 16235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13 إبريل، 2015 D | 13216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28 أغسطس، 2014 S | 5013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24 يوليو، 2013 A | 7618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30 إبريل، 2013 P | 17279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 4 مايو، 2011 P | 3052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 5 إبريل، 2011 D | 2815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 4 نوفمبر، 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29 يوليو، 2010 A | 10580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 1 مايو، 2009 P | 15849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 1 مايو، 2008 P | 1041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 1 مايو، 2008 P | 12188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 1 مايو، 2008 P | 4891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 1 مايو، 2008 P | 3024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 4 مايو، 2007 M | 4193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | مدير | 24 يوليو، 2026 A | 15471 | 0 | 0 | $0 |
| Diane M Bryant | مدير | 24 يوليو، 2026 A | 9664 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 8 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 6 فبراير، 2004 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 20 أغسطس، 2003 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 8 أغسطس، 2003 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 24 يونيو، 2003 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 19 يونيو، 2003 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 3 يونيو، 2003 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 27 مايو، 2003 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 15 يونيو، 2001 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 87 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61981 NS | 31 مايو، 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43927 NS | 30 إبريل، 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125093 NS | 30 إبريل، 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5836 NS | 30 إبريل، 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12701 NS | 31 مايو، 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201070 NS | 30 إبريل، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35814 NS | 31 مايو، 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29 مايو، 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41437 NS | 30 إبريل، 2026 | N-PORT |
| IWO · iShares Trust | 0,23% | 402938 SH | 8 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 75831 SH | 8 أغسطس، 2026 | يومي |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 47624 SH | 8 أغسطس، 2026 | يومي |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76694 NS | 31 مايو، 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17393 NS | 30 إبريل، 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29 مايو، 2026 | N-PORT |
| IJK · iShares Trust | 0,13% | 163140 SH | 8 أغسطس، 2026 | يومي |
| IWM · iShares Trust | 0,13% | 1201903 SH | 8 أغسطس، 2026 | يومي |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1703 NS | 30 إبريل، 2026 | N-PORT |
| XJH · iShares Trust | 0,12% | 6299 SH | 8 أغسطس، 2026 | يومي |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12097 NS | 30 إبريل، 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 24558 SH | 8 أغسطس، 2026 | يومي |
| SMDX · Tidal Trust III | 0,12% | 2419 NS | 30 إبريل، 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,11% | 27512 SH | 8 أغسطس، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 271486 SH | 8 أغسطس، 2026 | يومي |
| NUSC · Nushares ETF Trust | 0,11% | 23551 NS | 30 إبريل، 2026 | N-PORT |
| IJH · iShares Trust | 0,11% | 1603400 SH | 8 أغسطس، 2026 | يومي |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42163 NS | 30 إبريل، 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,11% | 5312 SH | 8 أغسطس، 2026 | يومي |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,10% | 74976 SH | 8 أغسطس، 2026 | يومي |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126817 NS | 31 مايو، 2026 | N-PORT |
| IJJ · iShares Trust | 0,09% | 94775 SH | 8 أغسطس، 2026 | يومي |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30 إبريل، 2026 | N-PORT |
| ESML · iShares Trust | 0,09% | 29374 SH | 8 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,09% | 20324 NS | 30 إبريل، 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,08% | 15968 SH | 8 أغسطس، 2026 | يومي |
| ITWO · ProShares Trust | 0,08% | 2210 NS | 31 مايو، 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5212 NS | 30 إبريل، 2026 | N-PORT |
| ISCV · iShares Trust | 0,07% | 6131 SH | 8 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,07% | 159737 NS | 30 إبريل، 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1606 NS | 31 مايو، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222776 NS | 31 مايو، 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12283 NS | 30 إبريل، 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 9034 SH | 8 أغسطس، 2026 | يومي |
| ISCB · iShares Trust | 0,06% | 1979 SH | 8 أغسطس، 2026 | يومي |
| SMLF · iShares Trust | 0,06% | 28701 SH | 8 أغسطس، 2026 | يومي |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30 إبريل، 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2220 NS | 31 مايو، 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1979 NS | 31 مايو، 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 302003 SH | 8 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,05% | 139826 SH | 8 أغسطس، 2026 | يومي |